Tianda Pharmaceuticals Limited (HKG:0455)

Tianda Pharmaceuticals Statistics

Total Valuation

HKG:0455 has a market cap or net worth of HKD 208.55 million. The enterprise value is 276.12 million.

Market Cap	208.55M
Enterprise Value	276.12M

Important Dates

The last earnings date was Thursday, March 26, 2026.

Earnings Date	Mar 26, 2026
Ex-Dividend Date	n/a

Share Statistics

HKG:0455 has 2.15 billion shares outstanding.

Current Share Class	2.15B
Shares Outstanding	2.15B
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	56.72%
Owned by Institutions (%)	n/a
Float	442.33M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.65
PB Ratio	0.46
P/TBV Ratio	0.68
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-3.94
EV / Sales	0.86
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.83, with a Debt / Equity ratio of 0.29.

Current Ratio	0.83
Quick Ratio	0.59
Debt / Equity	0.29
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-15.31

Financial Efficiency

Return on equity (ROE) is -14.61% and return on invested capital (ROIC) is -10.32%.

Return on Equity (ROE)	-14.61%
Return on Assets (ROA)	-4.47%
Return on Invested Capital (ROIC)	-10.32%
Return on Capital Employed (ROCE)	-10.62%
Weighted Average Cost of Capital (WACC)	2.46%
Revenue Per Employee	517,540
Profits Per Employee	-112,175
Employee Count	624
Asset Turnover	0.43
Inventory Turnover	4.47

Taxes

In the past 12 months, HKG:0455 has paid 926,000 in taxes.

Income Tax	926,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -46.11% in the last 52 weeks. The beta is -0.28, so HKG:0455's price volatility has been lower than the market average.

Beta (5Y)	-0.28
52-Week Price Change	-46.11%
50-Day Moving Average	0.10
200-Day Moving Average	0.13
Relative Strength Index (RSI)	41.02
Average Volume (20 Days)	33,500

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, HKG:0455 had revenue of HKD 322.95 million and -70.00 million in losses. Loss per share was -0.03.

Revenue	322.95M
Gross Profit	133.31M
Operating Income	-54.09M
Pretax Income	-69.33M
Net Income	-70.00M
EBITDA	-24.41M
EBIT	-54.09M
Loss Per Share	-0.03

Balance Sheet

The company has 64.81 million in cash and 132.66 million in debt, with a net cash position of -67.85 million or -0.03 per share.

Cash & Cash Equivalents	64.81M
Total Debt	132.66M
Net Cash	-67.85M
Net Cash Per Share	-0.03
Equity (Book Value)	456.36M
Book Value Per Share	0.21
Working Capital	-40.67M

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Depreciation & Amortization	29.68M
Net Borrowing	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 41.28%, with operating and profit margins of -16.75% and -21.67%.

Gross Margin	41.28%
Operating Margin	-16.75%
Pretax Margin	-21.47%
Profit Margin	-21.67%
EBITDA Margin	-7.56%
EBIT Margin	-16.75%
FCF Margin	n/a

Dividends & Yields

HKG:0455 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-33.56%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on September 2, 1999. It was a forward split with a ratio of 1.5.

Last Split Date	Sep 2, 1999
Split Type	Forward
Split Ratio	1.5

Scores

Altman Z-Score	n/a
Piotroski F-Score	2